Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ORPH | MRNA | BMY | AMGN | GILD |
Company | Orphazyme A/S ADR | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
Open | 0.9060 | 107.43 | 47.39 | 273.45 | 67.47 |
High | 0.9571 | 108.23 | 47.50 | 274.35 | 67.90 |
Low | 0.8457 | 103.52 | 44.37 | 267.24 | 65.09 |
Last | 0.8700 | 106.18 | 44.70 | 269.38 | 65.27 |
Change | -0.0200 | -2.67 | -4.16 | -3.63 | -1.81 |
% Change | -2.25% | -2.45% | -8.51% | -1.33% | -2.70% |
Volume | 941,400 | 2,797,900 | 45,069,000 | 1,793,800 | 15,167,200 |
20-Day Average Volume | 1,980,090 | 3,138,250 | 12,858,170 | 2,149,580 | 6,861,520 |
Previous Close | 0.8900 | 108.85 | 48.86 | 273.01 | 67.08 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | No | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 0.9128 | 105.00 | 49.94 | 270.70 | 68.68 |
20-Day Raw Stochastic | 41.76% | 48.60% | 3.27% | 31.20% | 2.05% |
20-Day Relative Strength | 36.52% | 53.03% | 28.31% | 44.80% | 28.32% |
Weighted Alpha | -87.89 | -11.43 | -34.75 | +9.12 | -23.73 |
Today's Opinion | 100% Sell | 100% Buy | 88% Sell | 72% Sell | 100% Sell |
Previous Opinion | 100% Sell | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
Last Month's Opinion | 100% Sell | 72% Buy | 8% Sell | 24% Buy | 88% Sell |
Performance | |||||
5-Days | |||||
%Chg | -2.47% since 03/23/22 | +4.10% since 04/18/24 | -7.45% since 04/18/24 | +2.52% since 04/18/24 | -1.35% since 04/18/24 |
Low | 0.8275 on 03/29/22 | 99.30 on 04/22/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 |
High | 0.9600 on 03/29/22 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 |
1-Month | |||||
%Chg | -28.69% since 02/28/22 | -3.81% since 03/25/24 | -14.45% since 03/25/24 | -4.07% since 03/25/24 | -10.07% since 03/25/24 |
Low | 0.5101 on 03/14/22 | 97.00 on 04/03/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 |
High | 1.3720 on 03/10/22 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
3-Month | |||||
%Chg | -67.29% since 12/28/21 | +3.28% since 01/25/24 | -9.90% since 01/25/24 | -13.18% since 01/25/24 | -18.65% since 01/25/24 |
Low | 0.5101 on 03/14/22 | 84.06 on 02/13/24 | 44.37 on 04/25/24 | 260.68 on 04/19/24 | 65.09 on 04/25/24 |
High | 2.7500 on 01/03/22 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 |
6-Month | |||||
%Chg | -79.33% since 09/28/21 | +38.33% since 10/25/23 | -21.04% since 10/25/23 | -1.02% since 10/25/23 | -16.74% since 10/25/23 |
Low | 0.5101 on 03/14/22 | 62.55 on 11/02/23 | 44.37 on 04/25/24 | 249.70 on 10/31/23 | 65.09 on 04/25/24 |
High | 5.4900 on 10/13/21 | 115.97 on 01/08/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
Key Statistics | |||||
Market Capitalization, $K | 30,721 | 41,676,488 | 99,027,448 | 146,436,016 | 83,519,768 |
Shares Outstanding, K | 35,312 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
Annual Sales | 0 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
Annual Net Income | -97,010,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
Last Quarter Sales | N/A | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
Last Quarter Net Income | N/A | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
60-Month Beta | 1.68 | 1.62 | 0.39 | 0.58 | 0.19 |
Per-Share Information | |||||
Most Recent Earnings | N/A | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
Latest Earnings Date | 04/05/22 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 6.53 | 14.67 | 9.97 |